Notice: This company has been marked as potentially delisted and may not be actively trading. Infinity Pharmaceuticals (INFI) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Thinking of Trying Collagen? What to Know About the Benefits and DrawbacksSeptember 29, 2024 | msn.comParticle Size Analysis Market Size to Reach US$ 816.10 Million by 2032 With an Emerging CAGR of 5.88% | Report by SNS InsiderSeptember 20, 2024 | finance.yahoo.comTriple Negative Breast Cancer Clinical Trials, Treatment Drugs, Pipeline Insights, and Companies 2024September 20, 2024 | theglobeandmail.comCollagen Supplements: What They Can Do for Your Body and What to Watch ForSeptember 18, 2024 | msn.comCollagen Supplements: Benefits, Drawbacks and How to Add It to Your DietAugust 30, 2024 | msn.comWoman shot while driving in South MemphisAugust 20, 2024 | msn.comYoung player Memphis just traded attends Ja Morant's partyAugust 16, 2024 | msn.comHigh Court orders issue of notice to Karnataka govt. on petition to transfer Valmiki scam case to CBIJuly 23, 2024 | msn.comSeaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive AppointmentsMay 7, 2024 | finance.yahoo.comQ1 2024 Glaukos Corp Earnings CallMay 2, 2024 | finance.yahoo.comPi Day: How One Irrational Number Made Us ModernMarch 16, 2024 | nytimes.comBiotech bankruptcies hit a record despite sector’s recoveryMarch 14, 2024 | msn.comDavid Schnell's Net WorthMarch 13, 2024 | benzinga.comMemphis Police issue alert after mother and two children abductedMarch 11, 2024 | msn.comStryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and AnkleJanuary 31, 2024 | finance.yahoo.comAGNPF Algernon Pharmaceuticals Inc.December 22, 2023 | seekingalpha.comInfinity Pharmaceuticals Inc INFIQDecember 12, 2023 | morningstar.comINFIQ Infinity Pharmaceuticals, Inc.December 1, 2023 | seekingalpha.comINFI DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities ...October 16, 2023 | businesswire.comFINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $500,000 to Contact the FirmOctober 16, 2023 | barrons.comInfinity Ongoing Deadline AlertOctober 15, 2023 | stockhouse.comDeadline Alert: Bronstein, Gewirtz & Grossman LLC Announces that Infinity Pharmaceuticals, Inc. (INFI) Investors Have OpportuniOctober 14, 2023 | bloomberg.comInfinity Pharmaceuticals, Inc. (INFIQ)October 10, 2023 | finance.yahoo.comBronstein, Gewirtz & Grossman LLC Notifies Infinity Pharmaceuticals, Inc. (INFI) Investors of Class Action and to Actively Participate!October 9, 2023 | barrons.comGutted Cambridge biotech declares bankruptcy after failed merger, layoffsOctober 2, 2023 | bizjournals.comInfinity Investor Shareholder AlertOctober 1, 2023 | markets.businessinsider.comInfinity Pharmaceuticals reportedly files for Chapter 11September 29, 2023 | msn.comFaron Pharmaceuticals Oy: Faron Pharmaceuticals Announces Board ChangesSeptember 22, 2023 | finanznachrichten.deINVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 18, 2023 | stockhouse.comINFINITY DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Infinity To Contact Him Directly To Discuss Their OptionsSeptember 16, 2023 | prnewswire.comROSEN, A TOP RANKED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFISeptember 16, 2023 | markets.businessinsider.comINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 15, 2023 | stockhouse.comSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 14, 2023 | stockhouse.comDirector Adelene Perkins Sells 410,196 Shares of Infinity Pharmaceuticals Inc (INFI)September 13, 2023 | gurufocus.comSHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 13, 2023 | stockhouse.comInfinity Pharmaceuticals receives delisting determination letter from NasdaqSeptember 13, 2023 | seekingalpha.comINVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 11, 2023 | stockhouse.comINFI Stockholders Should Contact Robbins LLP for Information About the Class Action Involving Infinity Pharmaceuticals, Inc.September 6, 2023 | benzinga.comInfinity Shareholder NoticeSeptember 6, 2023 | stockhouse.comDEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 6, 2023 | finanznachrichten.deThree execs leave Infinity Pharmaceuticals after failed merger, layoffsSeptember 5, 2023 | finance.yahoo.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSeptember 2, 2023 | stockhouse.comINFI Stock News: Investors with Significant Losses in Infinity Pharmaceuticals, Inc. Should Contact Robbins LLP About RecoveryAugust 28, 2023 | benzinga.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFIAugust 27, 2023 | prnewswire.comInfinity Shareholder Action ReminderAugust 25, 2023 | markets.businessinsider.comInfinity Pharmaceuticals, Inc. (INFI) Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Infinity Pharmaceuticals, Inc. Securities Class ActionAugust 24, 2023 | businesswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFIAugust 23, 2023 | benzinga.comInfinity Pharmaceuticals, Inc. (INFI) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Filed Against Infinity Pharmaceuticals, Inc.August 21, 2023 | benzinga.comROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFIAugust 20, 2023 | prnewswire.comINFINITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the FirmAugust 19, 2023 | businesswire.com Get Infinity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INFI and its competitors with MarketBeat's FREE daily newsletter. Email Address First JFK… next Elon? (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger. I share with you in this special investigative documentary. INFI Media Mentions By Week INFI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INFI News Sentiment▼0.000.60▲Average Medical News Sentiment INFI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INFI Articles This Week▼00▲INFI Articles Average Week Get Infinity Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INFI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Molecular Templates News Today Amgen News Today Vertex Pharmaceuticals News Today Gilead Sciences News Today Regeneron Pharmaceuticals News Today Alnylam Pharmaceuticals News Today Biogen News Today United Therapeutics News Today Neurocrine Biosciences News Today Incyte News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INFI) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Infinity Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Infinity Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INFI Stock Alerts